I find this very hard to believe. I know first hand that even with small projects when Teva is involved they insist on taking every molecule or procedure and test them in-house before moving to the next step. And it's not that Teva doesn't have the ability or knowledge to do MALDI-MS, ESI-MS, HPLC, NMR and such to characterize enoxaparin (although not to the higher quality Momenta can).
MNTA: is this information patently known throughout the analyst community? If this is true, I feel much more confident in this investment. Thanks for this vital piece of info!